Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05123950 · ClinicalTrials.gov registry record
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 304
- Enrollment target
NCT05123950 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 304 participants.
The verdict
NCT05123950 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
Study Summary
The purpose of this observational study is to collect real-world data that describes treatment patterns and clinical outcomes in participants with first line recurrent/metastatic squamous cell carcinoma of the head \& neck (1L R/M SCCHN).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2021-03-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05123950
The ClinicalTrials.gov registry entry for NCT05123950 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05123950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05123950 about?
NCT05123950 is a clinical study titled "A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe". The purpose of this observational study is to collect real-world data that describes treatment patterns and clinical outcomes in participants with first line recurrent/metastatic squamous cell carcinoma of the head \& neck (1L R/M SCCHN).
What is the current status of trial NCT05123950?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2019-01-01. Estimated completion is 2021-03-19.
Who is sponsoring clinical trial NCT05123950?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.